Sat, Jan 31, 2015, 9:45 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Gilead Sciences Inc. Message Board

  • iq180plus iq180plus May 10, 2014 5:31 PM Flag

    You turds DO realize EPS witll be over $2 for Q2 $8 annuilized. That's $8 a share as of now.....

    as in this quarter, $8, now, currently, and the ramp up hasn't yet hit it's stride, as in, Europe, Japan, Canada, Astrailia, etc. Europe market as large as US, and Japan, Cananda etc, at least half, meaning a whole lot of grouwth still on the horizon.
    Sure their will be competition, but even with a third of a mature market will mean revenuuses of well over 10 million a year for years to come.
    No, I don't think they deserve a huged mutilple of whatever the repeatable mature market run rate, as they will have a hudge core rev runrate rate they will need to grow of of, but a 12 times 8 a share current run rate gets one to a $96 share price.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Well form one turd to another. Surprise you must be the last one to know this since it`s been talked about for months that GILD may do $ 9.00 . They did about a buck on Sovaldi sales of 2 billion. That's mean on 12 billion in sales at least $ 6.00 per share plus the normal $ 2.00 all other drugs. Don`t tell us . We are at the mercy of the big guys.

      Sentiment: Strong Buy

104.83+0.65(+0.62%)Jan 30 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.